Case Details
- Case Title: ANG PENG TIAM v SINGAPORE MEDICAL COUNCIL
- Citation: [2017] SGHC 143
- Court: High Court of the Republic of Singapore
- Division/Panel: Court of Three Judges
- Date of Decision: 27 June 2017
- Date of Hearing/Reserving Judgment: 13 February 2017 (judgment reserved)
- Judges: Sundaresh Menon CJ, Andrew Phang Boon Leong JA, Judith Prakash JA
- Applicant/Appellant: Ang Peng Tiam
- Respondent/Appellant: Singapore Medical Council
- Procedural Posture: Two originating summonses: (1) Dr Ang’s appeal against conviction; (2) SMC’s appeal against sentence
- Originating Summons No: 8 of 2016 (Dr Ang v SMC)
- Originating Summons No: 9 of 2016 (SMC v Dr Ang)
- Legal Area(s): Professions; Medical profession and practice; Professional conduct; Professional disciplinary proceedings
- Statute(s) Referenced: Medical Registration Act (Cap 174, 2004 Rev Ed)
- Key Statutory Provision(s): Section 55(1) (appeals to the High Court); Section 53(1)(d) (professional misconduct)
- Disciplinary Tribunal (DT) Decision Date: 16 July 2016
- DT Charges: Two charges of professional misconduct under s 53(1)(d)
- DT Outcome: Convicted on two charges; acquitted on two other charges (no appeal against acquittal)
- DT Sentence: Aggregate fine of S$25,000
- High Court Appeals: Dr Ang challenged conviction on both charges; SMC challenged sentence as manifestly inadequate
- Length of Judgment: 65 pages; 21,322 words
- Cases Cited: [2017] SGCA 38; [2017] SGHC 143
Summary
In Ang Peng Tiam v Singapore Medical Council [2017] SGHC 143, the High Court (three judges) considered appeals arising from disciplinary proceedings under the Medical Registration Act. Dr Ang, a medical oncologist in private practice, was convicted by a Disciplinary Tribunal (“DT”) of two charges of professional misconduct under s 53(1)(d) of the Medical Registration Act. The convictions concerned, first, a false representation to a patient about the likelihood of disease control with chemotherapy and/or targeted therapy, and second, a failure to offer an alternative surgical treatment option.
The High Court heard two originating summonses: Dr Ang appealed against his convictions on both charges, while the Singapore Medical Council (“SMC”) appealed against the DT’s sentence, arguing that the aggregate fine of S$25,000 was manifestly inadequate. The court’s analysis focused on the proper legal approach to professional misconduct, the evidential and clinical basis for the representations made to the patient, and the disciplinary sentencing framework for medical practitioners.
Ultimately, the High Court upheld the DT’s findings on conviction and addressed the adequacy of the sentence in light of the seriousness of the misconduct and the need for deterrence and protection of the public. The decision is significant for how the courts evaluate departures from professional standards in medical disciplinary cases, particularly where clinical decisions and patient communications intersect.
What Were the Facts of This Case?
The underlying facts were largely undisputed. The patient, MT, was 55 years old and was first seen by Dr Ang on 30 March 2010 at Parkway Cancer Centre (“PCC”) in Mount Elizabeth Hospital, following investigations at Tan Tock Seng Hospital that suggested she might have lung cancer. Dr Ang arranged for blood tests and imaging, including an MRI of the brain and a PET-CT scan. However, he did not order an epidermal growth factor receptor (“EGFR”) analysis to determine MT’s EGFR mutation status. The judgment later treated the absence of EGFR testing as material to the first charge.
On 31 March 2010, MT returned to Dr Ang for a consultation to review the test results. Dr Ang explained that the PET-CT scan showed a large FDG-avid mass in the upper lobe of MT’s right lung, with central necrosis and satellite nodules. The court described the clinical meaning of PET-CT findings: FDG uptake is suggestive of aggressive tumour activity, and a higher SUVmax indicates active malignancy. Dr Ang also informed MT that the MRI did not show metastatic disease in the brain and that a biopsy was required to confirm whether the mass was cancerous.
MT underwent a biopsy later that day. At a further consultation on 1 April 2010, Dr Ang informed MT and her family that the biopsy confirmed cancer, diagnosing adenocarcinoma. He recommended chemotherapy using gemcitabine and cisplatin, together with targeted therapy using gefitinib (Iressa) on an alternate-day dosage. During this consultation, a family member recorded part of Dr Ang’s explanation in Mandarin. The recording, translated, included Dr Ang’s statement that he felt there was “at least a 70% chance” that the tumour would shrink and that this was a “very high percentage.” He also made remarks comparing the odds to a casino scenario, conveying confidence in the likelihood of disease control.
The agreed statement of facts before the DT clarified that Dr Ang’s “70% chance” assessment was premised on four phenotypes: MT being Chinese, being female, being a “never-smoker,” and having adenocarcinoma. Dr Ang had documented these factors on a memo and wrote “70%” with diagrammatic indications intended to reflect tumour shrinkage. MT subsequently underwent the recommended treatment. Her disease did not respond well; it progressed and she died in October 2010, a little more than six months after the consultation.
What Were the Key Legal Issues?
The first cluster of issues concerned whether Dr Ang’s conduct amounted to “professional misconduct” under s 53(1)(d) of the Medical Registration Act. The DT had proceeded under the first limb of the professional misconduct framework articulated in Low Cze Hong v Singapore Medical Council [2008] 3 SLR(R) 612, namely that the alleged misconduct constituted an intentional, deliberate departure from standards observed or approved by members of the profession. The High Court therefore had to examine whether the DT was correct in concluding that Dr Ang’s actions met this threshold.
For the first charge, the legal issue was whether Dr Ang made a false representation to MT about the likelihood of disease control with chemotherapy and/or targeted therapy, and whether the representation was false because it was not supported by appropriate clinical testing—specifically, the lack of EGFR analysis. The court had to assess whether the “70% chance” statement was grounded in an evidential basis that could justify such a confident prediction, and whether the absence of EGFR testing rendered the statement misleading or false in a legally relevant sense.
For the second charge, the issue was whether Dr Ang failed to offer MT the option of surgery. The charge alleged that surgery was a viable treatment option for MT’s stage of lung cancer (cT3 N0 M0, stage IIB) and ought to have been presented to the patient. The High Court needed to consider the scope of a doctor’s duty to inform patients of alternative treatment options, and whether the DT correctly characterised Dr Ang’s omission as an intentional, deliberate departure from professional standards.
Finally, on sentencing, the SMC argued that the DT’s aggregate fine was manifestly inadequate. The High Court had to determine the appropriate disciplinary response, considering the seriousness of the misconduct, the need for deterrence, and the protection of the public, as well as the proportionality of the sanction.
How Did the Court Analyse the Issues?
The High Court’s reasoning began with the disciplinary framework for professional misconduct. By adopting the Low Cze Hong approach, the court focused on whether the conduct involved an intentional and deliberate departure from standards observed or approved by members of the medical profession. This is a demanding standard: it is not enough that the doctor’s decision was merely suboptimal or that hindsight reveals a poor outcome. The court therefore examined whether Dr Ang’s conduct reflected a deliberate disregard of professional norms, particularly in relation to patient communication and clinical decision-making.
On the first charge, the court analysed the “70% chance” representation in context. The agreed facts showed that Dr Ang conveyed a high probability of disease control with chemotherapy and/or targeted therapy and that this assessment was premised on four phenotypes. The DT had found that a 70% disease control rate was only achievable in patients with EGFR mutation. The High Court accepted that EGFR mutation status was material to the predictive value of targeted therapy outcomes. Since Dr Ang did not order EGFR testing, the court considered whether he nevertheless made a confident prediction that effectively assumed EGFR mutation status without the necessary clinical basis.
The court also treated the nature of the representation as legally significant. The statement was not framed as speculative or conditional; it was communicated as a “very high percentage” likelihood of shrinkage and control. The judgment emphasised that patient counselling in oncology often requires careful calibration of probabilities, and that where a doctor makes a specific numerical prediction, the doctor must have a defensible clinical basis for that figure. In this case, the absence of EGFR analysis meant that the “70%” figure could not be justified by objective testing. The court therefore upheld the DT’s conclusion that the representation was false in the relevant legal sense and that it amounted to a deliberate departure from professional standards.
On the second charge, the court examined the duty to offer viable alternatives. The DT had convicted Dr Ang for failing to offer surgery as a treatment option. The charge was premised on MT’s stage of lung cancer and the viability of surgery for that stage. The High Court’s analysis reflected that informed consent in medical practice is not limited to obtaining agreement to a proposed plan; it includes presenting reasonable and viable alternatives. Where surgery is a viable option, failing to raise it deprives the patient of the opportunity to make an informed choice.
In assessing whether the omission was an intentional, deliberate departure, the court considered the professional expectations of oncologists managing stage IIB lung cancer. The judgment treated the failure to inform MT of surgery not as a mere error of judgment but as a departure from standards that require disclosure of material treatment options. The court therefore found that the DT was correct to characterise the omission as professional misconduct under s 53(1)(d).
Turning to sentencing, the High Court considered the SMC’s submission that the fine was manifestly inadequate. While the DT had imposed an aggregate fine of S$25,000, the SMC sought suspension for at least six months for each charge. The High Court’s approach to sentence in disciplinary matters typically involves assessing the gravity of the misconduct, the need for deterrence, and the protection of the public, while ensuring proportionality. The court weighed the seriousness of making a false representation about disease control and the failure to offer a viable alternative. It also considered that the misconduct related directly to patient counselling and treatment options—areas that are central to patient safety and trust in the medical profession.
What Was the Outcome?
The High Court dismissed Dr Ang’s appeal against conviction and upheld the DT’s findings on both charges of professional misconduct. The court agreed that Dr Ang’s “70% chance” representation was not supported by the necessary clinical testing and that his failure to offer surgery amounted to a deliberate departure from professional standards.
On the SMC’s appeal against sentence, the High Court addressed whether the DT’s aggregate fine was manifestly inadequate. Applying the disciplinary sentencing principles, the court substituted or adjusted the DT’s sanction to reflect the seriousness of the misconduct and the need for deterrence and public protection.
Why Does This Case Matter?
This case matters because it illustrates how Singapore courts evaluate professional misconduct where the doctor’s conduct involves both clinical decision-making and patient communication. The High Court’s approach underscores that numerical prognostic statements—especially those presented with confidence—must be grounded in appropriate clinical evidence. Where material tests are not performed, a doctor’s confident prediction may be treated as false or misleading in a manner that attracts disciplinary liability.
For practitioners, the decision reinforces the importance of EGFR testing in relevant lung cancer contexts and, more broadly, the duty to ensure that treatment recommendations and probability statements are supported by the appropriate diagnostic work-up. It also highlights that informed consent is not merely procedural; it requires disclosure of viable alternatives. Failure to offer a reasonable option such as surgery can be characterised as professional misconduct, even if the doctor ultimately provides treatment that is not the “best” option in hindsight.
From a disciplinary law perspective, the case is also useful for understanding the sentencing dimension. The court’s willingness to intervene where a sanction is manifestly inadequate signals that patient-facing misconduct—particularly involving false representations and omissions of material alternatives—will attract meaningful disciplinary consequences. Medical practitioners and their counsel should therefore treat disciplinary proceedings as a high-stakes risk area, where both the substance of clinical decisions and the manner of patient counselling will be scrutinised.
Legislation Referenced
- Medical Registration Act (Cap 174, 2004 Rev Ed), s 53(1)(d) [CDN] [SSO]
- Medical Registration Act (Cap 174, 2004 Rev Ed), s 55(1) [CDN] [SSO]
Cases Cited
Source Documents
This article analyses [2017] SGHC 143 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.